A Phase IV, Double Blind, Placebo-controlled, Randomized, Multi-Center Study to Evaluate the Efficacy of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke (HTZZP-INF)

NCT01758536 Phase 4 UNKNOWN

The purpose of this study is to determine the efficacy of Huatuo Zaizao Pills in improving neural function and life quality in patients with acute ischemic stroke in China.

Details

Lead sponsor	Huashan Hospital
Phase	Phase 4
Status	UNKNOWN
Enrolment	1100
Start date	2012-12
Completion	2014-12

Conditions

• Ischemic Stroke

Interventions

• Huatuo Zaizao Pills

Primary outcomes

• modified Rankin Scale — 3 months
  The primary end point is the proportion of patients with a modified Rankin Scale (mRS) score of 0 to 1 at 3 months.

Countries

China